Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-09-21 to 2023-10-13
Current total value of award: $9778.46
Description: 4562614641!TYSABRI 300 MG/15 ML VIAL 15ML